The American Journal of Managed Care: COVID-19 Associated With Autoimmune, Autoinflammatory Connective Tissue Disorders Researchers highlighted the potential long-term consequences of COVID-19 on incident autoimmune and autoinflammatory connective tissue disorders in a recent study. A substantial risk of autoimmune and ... Specialty pharmacy and drug infusion company BioTek reMEDys, in honor of August being International Autoinflammatory Awareness Month, is calling for “enhanced education and awareness” around these ...
News Medical: Link between COVID-19 and long-term risk of autoimmune and autoinflammatory connective tissue disorders The study suggests that long-term monitoring and patient management are crucial after COVID-19. Study: Long-Term Risk of Autoimmune and Autoinflammatory Connective Tissue Disorders Following COVID-19. Link between COVID-19 and long-term risk of autoimmune and autoinflammatory connective tissue disorders Business Wire: TNF Pharmaceuticals Collaborates with DADA2 Foundation for Compassionate Use Study of Isomyosamine in Rare Pediatric Autoinflammatory Disease TNF Pharmaceuticals Collaborates with DADA2 Foundation for Compassionate Use Study of Isomyosamine in Rare Pediatric Autoinflammatory Disease
